A An inhibitory subclass of NK cell lectin-like receptors that interacts with CLASS I MAJOR HISTOCOMPATIBILITY ANTIGENS and prevents the activation of NK CELLS.
Antigens Ly has been studied across 9 research domains including 🔬 Oncology, 🛡️ Immunity, ✨ Skin & Hair, 🧠 Cognitive, 🧠 Focus & Attention. The primary research focus is 🔬 Oncology with 41% of studies addressing this area.
This evidence profile for Antigens Ly is generated deterministically from 32 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.